Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Difludiazepam

From Wikipedia, the free encyclopedia
(Redirected fromRo07-4065)
Chemical compound
Pharmaceutical compound
Difludiazepam
Legal status
Legal status
Identifiers
  • 7-chloro-5-(2,6-difluorophenyl)-1-methyl-1H-benzo[e] [1,4]diazepin-2(3H)-one
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC16H11ClF2N2O
Molar mass320.72 g·mol−1
3D model (JSmol)
  • Fc3cccc(F)c3C2=NCC(=O)N(C)c1ccc(Cl)cc12
  • InChI=1S/C16H11ClF2N2O/c1-21-13-6-5-9(17)7-10(13)16(20-8-14(21)22)15-11(18)3-2-4-12(15)19/h2-7H,8H2,1H3
  • Key:DUNFPASORLTEGN-UHFFFAOYSA-N

Difludiazepam[1] (Ro07-4065) is abenzodiazepine derivative which is the 2',6'-difluoro derivative offludiazepam. It was invented in the 1970s but was never marketed, and has been used as a research tool to help determine the shape and function of theGABAA receptors, at which it has an IC50 of 4.1nM.[2][3][4] Difludiazepam has subsequently been sold as adesigner drug, and was first notified to theEMCDDA by Swedish authorities in 2017.[5][6]

See also

[edit]

References

[edit]
  1. ^Maskell PD, Wilson NE. Designer Benzodiazepines: New Challenges and Treatment Options, in Corazza O, Roman-Urrestarazu. Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS. Taylor & Francis, 2019.ISBN 978-1-138-06830-8
  2. ^Winkler DA, Burden FR, Watkins AJ (January 1998). "Atomistic Topological Indices Applied to Benzodiazepines using Various Regression Methods".Quantitative Structure-Activity Relationships.17 (1):14–19.doi:10.1002/(SICI)1521-3838(199801)17:01<14::AID-QSAR14>3.0.CO;2-U.
  3. ^So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors".Journal of Medicinal Chemistry.39 (26):5246–5256.doi:10.1021/jm960536o.PMID 8978853.
  4. ^Maddalena DJ, Johnston GA (February 1995). "Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural networks".Journal of Medicinal Chemistry.38 (4):715–724.doi:10.1021/jm00004a017.PMID 7861419.
  5. ^Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA(PDF). Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol. 2018.ISBN 978-92-9497-348-1.
  6. ^Manchester KR, Waters L, Haider S, Maskell PD (July 2022)."The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepines".Forensic Toxicology.40 (2):349–356.doi:10.1007/s11419-022-00616-y.PMC 9715504.PMID 36454409.
1,4-Benzodiazepines
1,5-Benzodiazepines
2,3-Benzodiazepines*
Triazolobenzodiazepines
Imidazobenzodiazepines
Oxazolobenzodiazepines
Thienodiazepines
Thienotriazolodiazepines
Thienobenzodiazepines*
Pyridodiazepines
Pyridotriazolodiazepines
Pyrazolodiazepines
Pyrrolodiazepines
Tetrahydroisoquinobenzodiazepines
Pyrrolobenzodiazepines*
Benzodiazepine prodrugs
* atypical activity profile (notGABAA receptor ligands)
Alcohols
Barbiturates
Benzodiazepines
Carbamates
Flavonoids
Imidazoles
Kava constituents
Monoureides
Neuroactive steroids
Nonbenzodiazepines
Phenols
Piperidinediones
Pyrazolopyridines
Quinazolinones
Volatiles/gases
Others/unsorted
Retrieved from "https://en.wikipedia.org/w/index.php?title=Difludiazepam&oldid=1268847282"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp